TEHRAN (IRNA) – Iranian Vice President of Science and Technology Mustafa Qane’i said on Sunday that domestic pharmaceutical companies have managed to manufacture prototypes for six sanctioned medicines.
Qane’i said that 21 medicines out of the 41 that were under sanctions and needed a permit from the U.S. Treasury to be exported to Iran, are now being produced in the country by knowledge-based companies and ready to be exported.
Six other medical data-x-items have also been produced in recent years and will be industrially produced in a few years, added Qane’i.
Qane’i also said that only 14 data-x-items of medical equipment are not produced inside the country, and Iran's Department of Biotechnology Development is ready to support their domestic development.